throbber
Effects of Monomethylfumarate on Human
`Granulocytes
`
`Peter H. Nibbering,* Bing Thio,t Timo P.L. Zomerdijk,* Anja C. Bezemer,* Roderick L. Beijersbergen,* and
`Ralph van Furth*
`Departments of "Infectious Diseases and i"Dcrmatology, Univcrsiry Hospital, Leiden, The Netherlands
`
`Monomethylfumarate (MMF) is the most active metabolite
`of the new antipsoriasis drug Fumaderm. Because granulo(cid:173)
`cytes play an important role in the pathophysiology of psoria(cid:173)
`sis, the effects of this drug on the functional activities of these
`cells were investigated. MMF stimulated polarization and
`elastase release, and enhanced the intracellular killing ofbac(cid:173)
`teria by granulocytes. This compound suppressed the for(cid:173)
`myl-Met-Nle-Phe (FMLP) - stimulated respiratory burst in
`these cells. MMF and dimethyl fumarate but not its stereo(cid:173)
`isomer dimethyl maleate, fumaric acid, or dimethylmalate
`stimulated polarization of and elastase release by granulo(cid:173)
`cytes, indicating that methylated fumarate derivatives inter(cid:173)
`act with granulocytes in a specific fashion. MMF did not
`
`affect the binding of formyl-Nle-Leu-Phe-Nle-Tyr-Lys(cid:173)
`fluorescein isothiocyanate to the FMLP receptor on granulo(cid:173)
`cytes. This compound induced an increase in the intracellular
`Ca++ ([Ca++L) and cyclic adenosine monophosphate con(cid:173)
`centration.
`The agonistic effects of MMF on granulocytes are thought
`to be mediated by the rise in the [Ca++] i and the antagonistic
`effects by the increase in the cyclic adenosine monophos(cid:173)
`phate concentration. These effects of MMF on granulocytes
`may in part explain the beneficial action of methylated fuma(cid:173)
`rate derivatives on psoriatic skin lesions. ] In.vest Dermatol
`101:37-42,1993
`
`Psoriasis, a chronic inflammatory skin disease affecting up
`
`to 3% of the population, is characterized by epidermal
`hyperplasia and infiltration of lymphocytes and granu(cid:173)
`locytes into the skin [l,2J. Treatment is based on inhibi(cid:173)
`tion of the proliferation of epidermal cells and interfer(cid:173)
`ence in the inflammatory process. In addition to the present
`therapeutic regimens a new systemic antipsoriasis drug, which con(cid:173)
`sists of dimethyl fumarate (DMF) and monoethylfumarate (MEF) ,
`has been introduced with successful results [3,4]'* Monomethylfu(cid:173)
`marate (MMF), which is formed in the circulation by hydrolysis of
`DMF, is believed to be th e most potent metabolite of this drug.
`Granulocytes are retained at the epidermis by means of a number of
`factors [5 - 7]. The exact role of granulocytes in the pathophysiol(cid:173)
`ogy of psoriasis is not known. IL-8 in combination with TNF-a,
`which is also present in psoriatic skin lesions [2,5], stimulates granu(cid:173)
`locytes to produce reactive oxygen intermediates and proteolytic
`enzymes [8,9], which can damage epidermal cells and probably
`influence the growth and differentiation of keratinocytes. Because
`
`Manuscript received September 17, 1992; accepted for publication Febru(cid:173)
`ary 12, 1993.
`Reprint requests to: R. van Furth, Department of Infectious Diseases,
`Universiry Hospital, Building 1, C5-P, P.O. Box 9600, 2300 RC Leiden,
`The Netherlands.
`Abbreviations: db-cAMP, diburyryl-cyclic adenosine monophosphate;
`DMF, dimethylfumarate; DMM, dimethylmaleate; FA, fumaric acid; FITC,
`fluorescein isothiocyanate; FLPEP FITC, formyl-Nle-Leu-Phe-Nle-Tyr(cid:173)
`Lys-FITC; FMLP, formyl-Met-Leu-Phe; FURA2/ AM, pentakis (acetoxy(cid:173)
`methyl) ester of [1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-
`2-(2' -amino-S' -methylphenoxy)-ethane-N ,N ,N',N' -tetraacetic acid; hpf,
`high-power field; MEF, monoethylfumarate; MMF, monomethylfumarate;
`Tw, Tween 8.
`:j: Thio HB, van der SchroeR" JG, Nugteren-Huying WH, Vermeer BJ:
`Long-term therapy with dimethylfumarate and monoethylfumarate (Fuma(cid:173)
`derm) in psoriasis (in preparation).
`
`granulocytes play an important role in the pathophysiology of psori(cid:173)
`asis the beneficial effect of treatment with fumaric acid derivatives
`may be caused by its effects on granulocytes. The present study
`concerns the effects of MMF on granulocytes from healthy donors.
`
`MATERIALS AND METHODS
`Compounds Used to Stimulate Granulocytes Cells were in(cid:173)
`cubated with the following compounds: MMF (Sigma Chemical
`Co., St. Louis, MO), dimethyl fumarate (DMF; Merck, Darmstadt,
`Germany), dimethylmaleate (DMM; Merck), fumaric acid (FA;
`Merck), and S- or R-dimethylmalate (S-DMM and R-DMM; Jans(cid:173)
`sen Chimica, Geel, Belgium). In all experiments the pH of the stock
`solutions of these compounds was adjusted to about 7.2 with 0.1 N
`NaOH. At the concentrations and exposure time used in this study
`the stimuli did not affect cell viability, as determined by trypan blue
`exclusion and the lactate dehydrogenase release assay.
`For comparison, cells were stimulated with 10 to 100 nM for(cid:173)
`myl-Met-Leu-Phe (FMLP) (Sigma) or 1 nM rlL-8 (a gift from Dr. I.
`Lindley, Department of Immunostimulation, Sandoz Forschung(cid:173)
`sinstitut Gesellschaft H.B.H., Vienna, Austria). Because both
`FMLP and rlL-8 were dissolved in dimethylsulfoxide (Serva, Hei(cid:173)
`delberg, Germany) and diluted in PBS, cells were also exposed to
`PBS with an equivalent concentration of dimethylsulfoxide. Phor(cid:173)
`bol myristate acetate (PMA) and dibutyryl(db) -cyclic adenosine
`monophosphate (cAMP) were obtained from Sigma.
`
`Preparation of Human Leukocytes Buffy coats prepared from
`blood from healthy donors were diluted in PBS (pH 7.4) and then
`subjected to Ficoll-amidotrizoate (p = 1.077 gjml; Pharmacia Inc.,
`UPf-sala, Sweden) density centrifugation at 440 X g for 20 min
`[10 . Granulocytes were purified from the Ficoll-Amidotrizoate
`pellets by dextran 1 X g sedimentation (Plasmasteril, Fresenius
`A.G., Bad Homberg, Germany) at 37°C for 10 min followed by
`removal of the remaining erythrocytes by a single hypotonic lysis.
`
`0022-202X/93/S06.00 Copyright © 1993 by The Sociery for Investigative Dermatology, Inc.
`
`37
`
`Sawai (IPR2019-00789), Ex. 1024, p. 001
`
`

`

`38 NIBBERING ET AL
`
`THE JOURNAL OF INV ESTIGATIVE DERMATOLOGY
`
`The final cell suspensions consisted of 97 ± 2% granulocytes. The
`viability of the cell suspensions exceeded 95%, as determined by
`trypan blue dye exclusion.
`
`Measurement of Polarization of Granulocytes The assay to
`determine polarization of granulocytes was performed as described
`[11] with minor modifications. Briefly, 400-fLl aliquots of a suspe.n(cid:173)
`sion of 1 X 106 granulocytes/ml RPMI 1640 (Flow LaboratorIes
`Ltd., Irvine, UK) were incubated with 100 fLl of the stimulus di(cid:173)
`luted in RPMI 1640 at 3r C for 15 min. Incubation was stopped by
`the addition of 500 fLl 9% v /v formaldehyde in PBS; the cells were
`maintained in this fixative until light microscopical determination
`of the percentage of cells that were not spherical. Two different
`investigators each analyzed 200 cells from each preparation.
`
`Chemotaxis Assay Chemotaxis of granulocytes was measured
`with the 48-well microchemotaxis chamber (Neuroprobe, Cabin
`John, MD) assay as described (12). In short, chemotaxins 0: PBS
`were placed in the lower compartments. Two filters were adjusted
`between the lower and upper compartments. The lower filter had a
`pore width of 0.45 fLm and the upper filter of 8 fLm. Granulocytes
`were placed in the upper compartment and, after incubation for
`1.5 h instead of 2.5 h at 37 °C, the filters were fixed, stained, and
`cleared with xylene. The number of granulocytes that had passed
`the upperfilter was determined by light microscopy (magnification
`X 400). The results are expressed as the number of cells per 10
`high-power fields (hpf).
`
`Measurement of Elastase Release by Granulocytes Granulo(cid:173)
`in 137 mM NaCI, 2.7 mM KCI, 8.1 mM
`cytes suspended
`Na2HP04, 0.9 mM CaCI2 , 0.49 mM MgClz, 1.5 mM KHzP0 4 ,
`and 2.5 mg bovine serum albumin (BSA)/ml at a concentration of
`5 X 106 cells/ml were incubated with the indicated stimuli at 37 °C
`for 30 min. The reaction was stopped by transferring the tubes to
`crushed ice. After centrifugation at 500 X g for 10 min, samples of
`the cell-free supernatants were assayed for elastase activity utili~ing
`substrate S2484 (Kabivitrum, Stockholm, Sweden) as descnbed
`[13J. The absorbance of the reaction product after 60 min was read at
`405 nm using a Titertek multiscan (EFLAB, Helsinki, Finland).
`Granulocytes were incubated with 5 fLg cytochalasin E {Serva)/ml
`PBS under slow rotation (4 rpm) at 37°C for 5 min, washed, and
`suspended to a concentration of 5 X 106 cells/ml.
`
`Measurement ofIntracellular Killing of Mycobacterium fortui(cid:173)
`tum by Granulocytes Preparation ~f M. JortuJtul1l (ATCC
`12790, American Type Culture CollectIOn, RockVille, MD) and
`the assay to determine the intracellular killing of this mycobacter(cid:173)
`ium by granulocytes has been described [14]. Briefly,S X 106 gran(cid:173)
`ulocytes/ml Hanks' balanced salt solution (HBSS) (Oxoid Ltd.,
`Basingstoke, UK) containing 0.01 % gelatin and 0.01 % Tween 80,
`further called HBSS-gel-Tw, and 5 X 106 M. Jortuitum/ml HBSS(cid:173)
`gel-Tw were mixed and incubated in the presence of 10% v /v
`human serum at 37°C for 10 min. The supernatant contammg
`extracellular bacteria was discarded, the granulocytes washed, and
`then 5 X 106 granulocytes containing bacteria were stimulated with
`10% serum with or without 200 fLM MMF at 37°C. One and two
`hours after stimulation samples were taken and, after lysis of the
`granulocytes, the number of viable cell-associated bacteria was ?e(cid:173)
`termined microbiologically. As control, granulocytes contammg
`bacteria were incubated with MMF or no stimulus.
`
`Measurement of the Oxygen Consumption by Granulo(cid:173)
`cytes Oxygen consumption by granulocytes at rest and after stim(cid:173)
`ulation was determined polarographically [15]. In short, 300 fLl of a
`suspension of 2.5 X 1 06leukocytes/ml RPMI 16~0 ~ere added .to a
`thermostated vessel (3rC), and the oxygen tenSIOn In the medIUm
`was measured with a Clark electrode. The rate of oxygen consump(cid:173)
`tion was calculated from the slope of the oxygen tension trace over a
`period of 5 to 10 min. ~o discriminate between.oxygen c~nsum~­
`tion by the NADPH OXidase complex and the mltochondnal respI(cid:173)
`ration, cells were also stimulated in the presence of 1 mM NaN 3' an
`inhibitor of mitochondrial respiration.
`
`Measurement of Superoxide Anion Production by Granu,
`locytes Superoxide anion (02-) production by cytochalasin E ~
`incubated granulocytes at rest and after stimulation was assessed by
`the superoxide dismutase-inhibitable reduction of ferricytochrom~
`c (type IV; Sigma) as described [1 6] with minor modifications.
`Briefly, the stimulus was added to 1 X 106 cells/ml PBS supple(cid:173)
`mented with 1.2 mM CaCI 2 , 1 mM MgClz, 5 mM glucose.
`20 mM Hepes, and 0.1 mM ferricytochrome c at 3rC and th~
`absorbance at 550 nm was measured every 30 seconds during a
`1 O-min period. The production of superoxide anion by the cells was
`calculated from a standard curve obtained with reduced cy(cid:173)
`tochrome.
`
`Measurement of the NADPH Oxidase Activity in a Cell-Free
`System NADPH oxidase activity was measured by means of a
`C lark oxygen electrode at 2rC as the rate of oxygen consumption
`by the cytosolic and membranous components of NADPH oxidase
`that were isolated from granulocytes as described [17]. Briefly,
`360 plIO mM Hepes (pH 7.0) containing 0.17 M sucrose, 75 roM
`NaCI, 0.5 mM ethyleneglycol-bis-(-amino-ethylether)N,N' -tetra(cid:173)
`acetic acid (EGTA), 1 mM MgCI2 , 2 mM NaN3 • and 10 ILM
`GTPyS (Calbiochem Corp, La Jolla, CA) were mixed with 10111
`membranous components and 10 fLl cytosolic components, each of
`which is the equivalent of 1 X 106 granulocytes. Assembly of the
`NADPH oxidase complex was initiated by adding sodium dodecyl(cid:173)
`sulfate at a final concentration of 100 fLM and closing the reaction
`vessel. After 3 min, NADPH atafinal concentration of250 pM was
`added and the oxygen consumption measured.
`
`Determination of the Binding of FLPEP-FITC to Granulo(cid:173)
`cytes by FACS Analysis The fluorescent probe formyl-Nle(cid:173)
`Leu-Phe-Nle-Tyr-Lys -fluorescein isothiocyanate (FLPEP-FITC;
`Molecular Probes Inc., Eugene, OR) was used to determine binding
`to the receptor as described [19]. Briefly, granulocytes at a concen(cid:173)
`tration of 2 X 1.06 cells/ml buffer (pH 7.4) were incubated with
`various concentrations of FLPEP-FITC in the dark at 4 0 C for 60
`min and then the fluorescence of the cells was measured on a
`FACScan (Becton and Dickinson, Mountainville, CA) equipped
`with a 15 m W argon-ion laser. For assessment of the non-specific
`binding of this probe, cells were incubated with 1 fLM FMLP at 4 ° C
`for 15 min prior to addition ofFLPEP-FITC. The results expressed
`as mean fluorescence intensity values are in arbitrary units (AU).
`
`Competition Binding Assay for cAMP At selected intervals
`after stimulation, 50 fLl of a suspension of 1 X 106 granulocytes/ml
`were stimulated at 3rc for various intervals and then 450 fLl ice(cid:173)
`cold I-propanol (Merck) were added to disrupt the cells. After soni(cid:173)
`cation for 5 min this material was centrifuged at 7000 X g for 1 min
`and then the supernatant was lyophilized. The residue was dissolved
`in 100 fLl distilled water and the cAMP content of these samples was
`determined as described previously [19]. In short, cAMP in the
`samples was allowed to compete with 5',8-f3H]-cAMP (specific
`activity 40-60 Ci/mmol; Amersham International, Amersham,
`Bucks, UK) for binding to sites in the bovine microsomal prepara(cid:173)
`tion. The cAMP content of these samples was calculated from a
`standard curve constructed in parallel with unlabeled cAMP (Amer.
`sham). The cAMP concentration was calculated from this value and
`the mean cell volume of the granulocytes.
`
`Measurement of the [Ca++]; in Granulocytes For measure(cid:173)
`ment of the [Ca-] i, 2 X 107 leukocytes/ml 20 mM Hepes supple(cid:173)
`mented with 138 mM NaCI, 6 mM ICCI, 1 mM MgS04' 1.1 m.M
`CaCI2 , 1 mM NaH2P04, 5.5 mM D-glucose, 0.1 mMEGTA, and
`0.1 % BSA (Ca- buffer, pH 7.4) were incubated with 2 JlM of the
`acetoxymethyl ester of FURA-2 (FURA-2/ AM; Sigma) in the dark
`at 3rc for 30 min. Next. the cells were washed with Ca++ buffer
`and then suspended in either Ca- buffer or Ca++ buffer without
`CaCl 2 but supplemented with 2 mM EGTA, further called Ca++·
`free buffer. Two millimeter aliquots of 5 X 106 cells/ml Ca++
`buffer or Ca++-free buffer were transferred to a quartz cuvette with
`magnetic stirring. The cell suspensions were excited alternately at
`340, 360, and 380 nm (slit width 2.5 11m) and emission was
`
`Sawai (IPR2019-00789), Ex. 1024, p. 002
`
`

`

`VOL. 101, NO.1 JULY 1993
`
`EFFECTS OF MMF ON GRANULOCYTES 39
`
`100
`
`80
`
`~ 60
`!!!
`Q;
`u
`U
`
`.~ 40
`'" "0
`
`20
`
`0
`
`a. 00
`
`0
`
`0.2
`
`20
`2
`MMF (pM)
`
`200
`
`500
`
`Figure 1. Effect of various concentrations of MMF on the polarization of
`granulocytes. Granulocytes were incubated for 15 min with concentrations
`ofMMF ranging from 0.2.uM to 500 .uM and the percentage cells that were
`not spherical was assessed. Results are means ± SEM; 11 = 3.
`
`recorded at 500 nm (slit width 5 nm) with a Perkin-Elmer 3000
`spectrofluorometer (Perkin-Elmer, Ueberlingen, Germany). The
`[Ca++] i was calculated from the ratio of the fluorescence excited at
`340 nm and at 380 nm as described [20]. Calibration of the FURA-
`2 fluorescence was performed by lysis of the cells with 0.1 % wtjv
`Triton X-I00 (Sigma) in the presence of 1.1 mM CaClz and the
`subsequent addition of 10 mM EGT A.
`Statistical Analysis The significance of the differences between
`the values found for cells exposed to stimuli and cells incubated with
`the vehicule was determined with the Mann-Whitney U test. p <
`0.05 was considered significant.
`
`RESULTS
`Induction of the Polarization and Chemotaxis and Elastase
`Release by Granulocytes by Various Stimuli MMF induced
`polarization of granulocytes in a dose-dependent fashion; the maxi(cid:173)
`mum percentage polarized cells was obtained with 200 .aM MMF
`(Fig 1). DMF but not DMM, FA, S-DMM, or R-DMM stimulated
`the polarization of granulocytes (Table I). About 90% of the granu(cid:173)
`locytes had a polarized morphology after stimulation with FMLP
`(Table I).
`The number of cells in the upper filter was slightly but signifi(cid:173)
`cantly higher when MMF and DMF was present in the lower com-
`
`partment of the chambers than when no stimulus was applied
`(Table I). The effect on the number of cells in the filter did not
`depend on the concentration of MMF (range 2 nM to 2 mM; results
`not shown). These results indicate that MMF and DMF are hardly
`chemotactic for granulocytes; FMLP was a potent chemotaxin for
`these cells (Table I). Addition of MMF to the upper compartment of
`the n1.icrochemotaxis chamber did not affect this response to FMLP.
`Granulocytes incubated with MMF for 5 min responded to FMLP as
`well as cells incubated with PBS (results not shown). MMF but not
`DMF, DMM, FA, S-DMM, or R-DMM stimulated granulocytes to
`release elastase (Table I). Stimulation by MMF was considerably less
`than that by rIL-8 or FMLP (Table I). MMF-incubated granulocytes
`released significantly less elastase after rIL-8 or FMLP stimulation
`than PBS-incubated cells.
`
`Intracellular Killing of M. fortuitum by Granulocytes The
`phagocytosis of M. fortuitul1I by granulocytes and the growth of this
`bacterium in HBSS - gel-Tw were not affected by MMF (results not
`shown). The intracellular killing of M. Jortllitum by granulocytes
`stimulated with serum was limited but addition of MMF enhanced
`the killing process significantly; the percentage of M. Jortuitum
`killed 2 h after stimulation with and without MMF was 60 ± 4.5%
`and 29 ± 3.5% (means ± SEM; n = 3), respectively. In the absence
`of serum, intracellular killing of M. Jortuitul1I by granulocytes did
`not occur and MMF had no effect. The cell-free medium, obtained
`after incubation for 2 h at 37"C of 5 X 106 granulocytes and 5 X
`106 M. Jortuitul1I in 1 111.1 HBSS-gel-Tw containing 10% serum
`with MMF, did not affect the growth of M. Jortuitum, indicating
`that no extracellular killing of bacteria occurred (results not shown).
`Stimulation of Oxygen Consumption and O 2 Production by
`Granulocytes with MMF and FMLP Oxygen consumption
`and O 2 production by resting granulocytes and by granulocytes
`after stimulation with various concentrations of MMF, FMLP, or
`PMA are shown in Table II. Both MMF and FMLP stimulated
`oxygen consumption by these cells. Optimal concentrations for
`MMF and FMLP were 200.aM and 100 11.M, respectively. No addi(cid:173)
`tive effect of MMF on the FMLP-stimulated oxygen consumption
`by granulocytes was found (results not shown). In the presence of
`NaN3 , an inhibitor of mitochondrial respiration, the stimulatory
`effect of MMF on oxygen consumption was almost completely
`abolished whereas that of FMLP was hardly affected (Table II),
`indicating that MMF does not activate the NADPH oxidase com(cid:173)
`plex. In agreement with this notion, MMF did not stimulate granu(cid:173)
`locytes to produce 0 2". This compound did not scavenge 02".
`To find out whether incubation with MMF suppresses the
`FMLP-stimulated oxygen consumption, granulocytes were ex(cid:173)
`posed to MMF in the presence ofNaN 3 , or as control to PBS, prior
`
`Table I. Effects of Various Stimuli on the Polarization and Chemotaxis of, Elastase Release by, and Increase in the [Ca++t in Granulocytes
`
`Stimulus'
`
`Polarized Cellsb (%)
`
`Chemotaxis'
`(cell/tO hpf)
`
`Elastase Released
`(00405 nm)
`
`[Ca++]i'
`(nM)
`
`18 ± 3f
`0.30 ± 0.01
`60±6
`None
`58 ± 5g
`91 ± 109
`0.43 ± O.Ols
`MMF
`40 ± 5:
`113 ± 9:
`0.30 ± 0.01
`OMF
`0.27 ± 0.01
`NO
`18 ± 3
`OMM
`0.30 ± 0.02
`FA
`12 ± 2
`NO
`0.34 ± 0.01
`NO
`19 ± 4
`S-OMM
`0.31 ± 0.01
`NO
`12 ± 4
`R-OMM
`NOb
`1.61 ± O.llg
`NO
`rIL-8
`88 ± 3g
`1129 ± 308g
`2.10 ± 0.27:
`FMLP
`• Final concentration ofMMF, OMF, and OMM was 200 tIM; of FA, S-OMM, and R-OMM 1 mM; of rlL-8 1 nM. The final concentration ofFMLP in the polarization assay, the
`chemotaxis assay and the elastase release assay was 10 nM and for the measurement of the [Ca++]; it was 100 nM.
`b Various stimuli were added to granulocytes and after 15 min the percentage of cells that were not spherical was assessed. n = 3.
`, Various stimuli were included in the lower compartment of the microchemotaxis chamber and after an incubation for 1.5 h at 37 "C the number of cells in the upper filter was
`determined light microscopically. The results expressed as the number of cells per 10 hpf. n = 3.
`, Various stimuli were incubated with granulocytes for 30 min; after the reaction was terminated, the cell-frec supcrnatant of this suspension was assayed for elastase activity. n = 3.
`l Various stimuli were added to FURA 2/AM-incubatcd granulocytes and the [Ca++]j was monitored. Data represent max iinuln [Ca++]j vaJucs. n = 4- 16.
`fResults are means ± SEM.
`t Indicates p < 0.05 for the difference between the values for stimu lated and control cells.
`b NO, not done.
`
`110 ± 6
`258 ± 14g
`235 ± 8g
`129 ± 9
`119±1
`74 ± 10
`85 ± 4
`450 ± 26·~
`618 ±38g
`
`Sawai (IPR2019-00789), Ex. 1024, p. 003
`
`

`

`40 NIBBERING ET AL
`
`THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
`
`Table ll. Oxygen Consumption and Superoxide Anion Production by Granulocytes
`at Rest and After Stimulation with MMF, FMLP, and PMAa
`
`Incubation
`
`Stimulusb
`
`None
`PMA
`MMF
`FMLP
`MMF
`FMLP
`FMLP
`
`Oxygen Consumption
`(nmol/[5 X 106 cells X min)
`3 ± 2' (6)
`25 ± 5J (6)
`18 ± 6J (6)
`16 ± Y (8)
`2 ± 1 (6)
`15±4J (3)
`5±1'(3)
`
`O2 Production
`(I1mol/[l X 106 cells X 10 mjn))
`6 ± 0.4 (7)
`51±4J(5)
`6 ± 0.4 (7)
`34 ± 1J (7)
`N[)f
`ND
`24 ± 0.4' (7)
`
`• Oxygen consumption due to mitochondrial respiration was inhibited with 1 mM NaN,. Where indicated, granulocytes were incubated with MMF together with NaN , for 15
`min before measurement of rhe FMLP-stimulated oxygen consumption and O. production.
`• Final concentrations of200)JM MMF, 100 nM FMLP, 100 ng/m1 PMA, and 1 mM NaN, .
`, Results are means ± SEM, with the number of experiments in parentheses.
`, Indicates P < 0.05 for the difference between the values for stimulated and control cells.
`, Indicates p < 0.05 for the difference between the values for MMF-incubated and control cells.
`I ND, not done.
`
`to stimulation with FMLP. The results showed that the respiratory
`burst in MMF-incubated cells was significantly lower than in con(cid:173)
`trol cells (Table II). Because it has been suggested that an increase in
`the cAMP concentration inhibits the oxidative metabolism of gran(cid:173)
`incubated granulocytes with 0.1 mM
`ulocytes [21,22], we
`db-cAMP for 5 min at 37°C before measurement of the FMLP(cid:173)
`stimulated 02" production. The results revealed that the FMLP(cid:173)
`stimulated production of 02" by db-cAMP-incubated granulocytes
`was 40 ± 9% (mean ± SEM) less (n = 6) than that by control gran(cid:173)
`ulocytes.
`Effect ofMMF on the NADPH Oxidase Activity in the Cell(cid:173)
`Free System To elucidate the mechanisms underlying the inhibi(cid:173)
`tion of the respiratory burst in MMF-incubated cells, we measured
`the effect of MMF on the NADPH oxidase activity in the cell-free
`system. For this purpose MMF, or as control PBS, was added to the
`mixture of cytosolic and membranous components of the NADPH
`oxidase compl.ex before the addition ofSDS. The results revealed no
`effect of MMF on the NADPH oxidase activity; the results of the
`addition of MMF and PBS were 8.4 ± 0.2 J.LM oxygen/min and
`8.2 ± 0.6 JLM oxygen/min (means ± SEM; n = 5), respectively.
`Effect ofMMF on the Binding ofFLPEP-FITC to Granulo(cid:173)
`cytes To find out whether the MMF-mediated inhibition of the
`respiratory burst in granulocytes was due to down-regulation of the
`FMLP-receptor, the effect of MMF on binding of FLPEP-FITC to
`these cells was determined. The results revealed no effect of expo(cid:173)
`sure of the cells to MMF for 15 min prior to the incubation with the
`fluorescent probe (Fig 2). Addition of MMF during the incubation
`with FLPEP-FITC was without effect as well (results not shown).
`
`Changes in the cAMP Concentration in Granulocytes After
`Stimulation with MMF and FMLP Because an increase in the
`cAMP concentration in cells is involved in the negative feedback
`processes in cells [24], we investigated whether MMF induces a rise
`in the cAMP concentration in granulocytes. The cAMP concentra(cid:173)
`tion in resting granulocytes was 0.72 ± 0.19 J.LM (mean ± SEM;
`n = 4). Stimulation of granulocytes with MMF resulted in a tran(cid:173)
`sient increase in the cAMP concentration to a maximum value of
`1.33 ± 0.14 J.LM (mean ± SEM; n = 4) 20 seconds after stimula(cid:173)
`tion, which returned to resting values within 1 min after addition of
`the stimulus. FMLP induced a threefold increase in the cAMP con(cid:173)
`centration in granulocytes with a maximum value of 2.67 ±
`0.60 J.LM (mean ± SEM; n = 4) 30 seconds after stimulation.
`Changes in the [Ca++}; in Granulocytes Induced by Various
`Stimuli The [Ca++] i in resting granulocytes amounted to 110 ±
`6 nM (mean ± SEM; Table I). Addition of2 f1.M to 20 mM MMF to
`granulocytes induced a dose-dependent increase in the [Ca++Ji;
`maximum values were found after stimulation with 200 JLM MMF
`(Fig. 3). The rise in the [Ca++L was already apparent within 5
`seconds of the addition of MMF and the [Ca++] i gradually returned
`
`to resting values within the next 2 - 3 min. The increase in the
`[Ca++] i after stimulation with MMF is due mainly to the release of
`Ca+t from intracellular stores. Similar kinetics for changes in the
`[Ca++]; were found for granulocytes stimulated with FMLP and
`rlL-8 (results not shown). Furthermore, the FMLP-induced in(cid:173)
`crease in the [Ca++]; in MMF-incubated and PBS-incubated granu(cid:173)
`locytes did not differ (results not shown), indicating that MMF did
`not affect signaling in granulocytes.
`To find out whether the effects of methylated fumarate deriva(cid:173)
`tives on granulocytes depend on the presence of methyl groups, the
`changes in the [Ca++] i in granulocytes upon stimulation with DMF,
`DMM, FA, S-DMM, or R-DMM were assessed. The results reo
`vealed that of these compounds only DMF induced an increase in
`the [Ca++]; (Table I).
`
`DISCUSSION
`The main conclusion that can be drawn from the present results is
`that the methylated fumarate derivatives MMF and DMF modulate
`several functional activities of granulocytes. These fumarate deriva(cid:173)
`tives are agonists of granulocytes because they stimulate the polar(cid:173)
`ization and elastase release by granulocytes and enhance the intra·
`cell ular killing of bacteria by these cells. Some of these effects might
`be mediated by the rise in the [Ca+t] i in granulocytes stimulated by
`these compounds, since Ca++ -specific ionophores also stimulate the
`polarization and elastase release by granulocytes [23 - 25]. MMF and
`DMF are not chemotactic for granulocytes or stimulate the respira-
`
`300
`
`200
`
`100
`
`::
`'iii
`c:
`J!!
`.!:
`
`'" " c: '" " '" ~
`
`0
`~
`
`25
`FLPEP (nM)
`
`SO
`
`Figure 2. Effect of MMF on the binding of FLPEP-FITC to granulocytes,
`Granulocytes were exposed to 200 liM MMF ~, PBS (0). or 1 liM FMLP
`(0) for 15 min before jncubation with variolls concentrations of FLPEP,
`FITe.' After a 60-min incubation with this probe, the fluorescence of th~
`cells was measured with a FACScan f1owcytometer. The results are given fot
`one representative experiment out of three experiments.
`
`Sawai (IPR2019-00789), Ex. 1024, p. 004
`
`

`

`VOL. 101, NO.1 JULY 1993
`
`300
`
`~ 200
`
`.s -. .
`
`'" ~ u_~
`
`100
`
`0
`
`0 0.002 0.02 0.2
`
`20
`
`MMF (mM)
`
`Figure 3. Effect of various concentrations of MMF on the [Ca++] i in granu(cid:173)
`locytes. For investigation of the effect of MMF on the [Ca++]., FURA
`2/ AM-incubated granulocytes were stimulated with 2,uM to 20 mM MMF
`and the changes in the [Ca++]. monitored. Data, i.e., means ± SEM, repre(cid:173)
`sent the peak values (at 10 seconds) after stimulation. n = 3.
`
`tory burst in these cells. On the contrary, MMF suppressed the
`FMLP-stimulated respiratory burst in these cells; in this respect
`methylated fumarate derivatives are antagonists of granulocytes.
`What are the mechanisms underlying the inhibitory effect of
`MMF on the FMLP-stimulated respiratory burst? It could be that
`MMF interferes with the formation of the NADPH oxidase com(cid:173)
`plex. This possibility can be excluded because we found no effect of
`MMF on the NADPH oxidase activity in the cell-free system. An(cid:173)
`other possibility is that MMF down-regulates the FMLP receptor.
`Our observation that MMF did not affect the binding of FLPEP(cid:173)
`FITC to granulocytes or the FMLP-induced increase in the [Ca++].
`excludes the possibility that it inhibits expression of the receptor for
`FMLP or the signaling through this receptor. It may be that cAPK
`interferes with the signaling, which arises from the interaction be(cid:173)
`rween FMLP and its receptor [21,22], and thus inhibits the respira(cid:173)
`tory burst in granulocytes after stimulation with this ligand. This
`possibility could be correct because MMF induced an increase in the
`cAMP concentration, which can inhibit 02-production by granu(cid:173)
`locytes [22].
`Our observation that MMF induces polarization of granulocytes
`without being chemotactic for these cells is not in agreement with
`the generally accepted view that polarization of phagocytes is
`closely correlated to chemotactic responsiveness. This discrepancy
`cannot yet be explained. An increased adherence of MMF-stimu(cid:173)
`lated granulocytes to glass or plastic surfaces, as described for IgG
`stimulation [26], has not been observed. It has been reported that
`activation of protein kinase C in lymphocytes by phorbol esters
`leads to a decreased reaction to chemotactic stimuli [27]. Because
`MMF does not activate this enzyme in granulocytes (unpublished
`observations), this cannot explain the observed discrepancy. It thus
`appears that MMF induces a shape change rather than being chemo(cid:173)
`tactic for granulocytes.
`Previous studies showed that human granulocytes efficiently
`phagocytose M.JortuitulII whereas subsequent killing of the ingested
`bacteria is limited [14] .§ Because intracellular killing ofM.JortuitulII
`by granulocytes activated by interferon-y [14] or stimulated by IL-
`8§ is enhanced compared to normal granulocytes, we used this
`bacterium to investigate whether MMF also augments the intracel(cid:173)
`lular killing of this bacterium by granulocytes.
`Interactions between methylated fumarate derivatives and granu(cid:173)
`locytes are specific because compounds with an ethyl group (mon(cid:173)
`oethylfumarate; unpublished observations) instead of a methyl
`group or without a methyl group, i.e., fumaric acid, did not stimu-
`
`§ Nibbering PH, Pos 0, Stevenhagen A, van Furth R: Interleukin-8
`enhances the non-oxidative intracellular killing of Mycobacterium fortui(cid:173)
`tum by human granulocytes (submitted for publication).
`
`EFFECTS OF MMF ON GRANULOCYTES 41
`
`late polarization, degranulation, or changes in the [Ca++] i in granu(cid:173)
`locytes. The most convincing evidence for the specificity of the
`binding site for methylated fumarate derivatives is our observation
`that DMF, but not its stereoisomer DMM, stimulates granulocytes.
`Furthermore, we did not observe a change in the [Ca++] i or oxygen
`consumption by purified monocytes after stimulation with MMF
`(unpublished observations), indicating that methylated fumarate
`derivatives react with cells in a selective fashion .
`The present results indicate that MMF suppresses the production
`and release of important mediators of the inflammatory process,
`such as reactive oxygen intermediates and elastase. In addition to
`these effects on granulocytes, MMF suppresses the proliferation of
`human cultured keratinocytes and SVK 14 keratinocyte cell-line
`cells (unpublished observations). The therapeutic effect of methyl(cid:173)
`ated fumarate derivatives in psoriasis can most probably be ex(cid:173)
`plained by its anti-inflammatory effects on granulocytes and its
`anti proliferative effects on keratinocytes.
`
`Tllis 1V0rk was 5Ilpported by a gratlt from the Kasswaars F,md, University Hospital
`Leidw, Tire Netlrerlands. We thank M. TIL IIa" dell Barselaar, A . Steve"hagen, atld
`C. Widijanto for tlreir ted'tlical assiSlarlCe a"d Dr. L. KOelldenllm, (Department of
`PlIlmo"ary Diseases, U"iversity Hospit

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket